Journal
ANESTHESIOLOGY
Volume 125, Issue 2, Pages 333-345Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ALN.0000000000001199
Keywords
-
Categories
Funding
- Department of Anesthesia, Critical Care and Pain Medicine at Massachusetts General Hospital, Boston, Massachusetts
- State of Maryland Technology Development Corporation (TEDCO), Columbia, Maryland
- National Institutes of Health, Bethesda, Maryland [R01 HL117871, R01 CA168365]
- Howard Hughes Medical Institute (Chevy Chase, Maryland)
Ask authors/readers for more resources
Background: Calabadion 2 is a new drug-encapsulating agent. In this study, the authors aim to assess its utility as an agent to reverse general anesthesia with etomidate and ketamine and facilitate recovery. Methods: To evaluate the effect of calabadion 2 on anesthesia recovery, the authors studied the response of rats to calabadion 2 after continuous and bolus intravenous etomidate or ketamine and bolus intramuscular ketamine administration. The authors measured electroencephalographic predictors of depth of anesthesia (burst suppression ratio and total electroencephalographic power), functional mobility impairment, blood pressure, and toxicity. Results: Calabadion 2 dose-dependently reverses the effects of ketamine and etomidate on electroencephalographic predictors of depth of anesthesia, as well as drug-induced hypotension, and shortens the time to recovery of righting reflex and functional mobility. Calabadion 2 displayed low cytotoxicity in MTS-3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium-based cell viability and adenylate kinase release cell necrosis assays, did not inhibit the human ether-a-go-go-related channel, and was not mutagenic (Ames test). On the basis of maximum tolerable dose and acceleration of righting reflex recovery, the authors calculated the therapeutic index of calabadion 2 in recovery as 16: 1 (95% CI, 10 to 26: 1) for the reversal of ketamine and 3: 1 (95% CI, 2 to 5: 1) for the reversal of etomidate. Conclusions: Calabadion 2 reverses etomidate and ketamine anesthesia in rats by chemical encapsulation at nontoxic concentrations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available